Boehringer Ingelheim launches three phase III trials in precision Oncology
Boehringer Ingelheim has initiated three Phase III clinical trials aimed at advancing…
Burjeel Cancer Institute Honors 15 Cancer Survivors at ‘Circle of Hope’ Event
Burjeel Cancer Institute honored 15 cancer survivors during its ‘Circle of Hope’…
UAE Approves New Oral Breast Cancer Treatment for Hormone-Resistant Cases
The UAE has approved AstraZeneca’s Etcamah, a new oral therapy for advanced…
LCRF and AstraZeneca Launch Research Awards to Advance Small Cell Lung Cancer Treatment
The Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca, has announced…
IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy
IBA has entered into a sponsored research agreement with The University of…
American Cancer Society Scientists to Present Cancer Research Advancements at 2026 ASCO Annual Meeting
This year’s American Society of Clinical Oncology meeting to be held in…
Theromics Appoints Andrew C. Zeringue as Chief Executive Officer
Theromics Inc. has appointed Andrew C. Zeringue as Chief Executive Officer, bringing…
ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory to Expand BCG Supply in the United States
ImmunityBio has signed an exclusive U.S. development and supply agreement with Japan…
WHEN THE FIGHT AGAINST CANCER BECOMES A COLLECTIVE ACT OF HOPE
Cycle Against Cancer is a powerful endurance initiative uniting 13 cyclists on…
Philips receives FDA 510(k) clearance for its Rembra platform
Philips has received FDA 510(k) clearance for its Rembra platform, including Rembra…
